Overview A Study to Assess the Effects of MK0822 in Reducing the Risk of Bone Metastasis in Women With Breast Cancer (0822-029) Status: Withdrawn Trial end date: 2008-09-01 Target enrollment: Participant gender: Summary The purpose of this study is to test MK0822 on reducing the risk of bone metastasis in women with breast cancer. Phase: Phase 3 Details Lead Sponsor: Merck Sharp & Dohme Corp.